Skip to main content
. Author manuscript; available in PMC: 2015 Nov 16.
Published in final edited form as: Int J Gynecol Pathol. 2012 Mar;31(2):151–159. doi: 10.1097/PGP.0b013e318226b376

Figure 2.

Figure 2

Strong and uniform nuclear PAX2 expression was characteristic of normal proliferative endometrium (A) and secretory endometrium (B). Occasional partial loss of PAX2 expression did occur in background histologically normal endometrium (C). Complete loss of nuclear PAX2 expression was much more characteristic of complex hyperplasia (D), atypical hyperplasia (E) and FIGO grade 1 endometrioid carcinoma (F).